Intraoperative autotransfusion system Xtra™

It brings together three decades of experience and improvements in cell salvage procedures, treating more than 0.5 million patients per year. Ready to meet any surgical scenario: from scheduled treatments to emergency situations and everything in between Performance where you need it Consistently high RBC hematocrit and wash quality with standard protocol Excellent heparin and protein removal High RBC recovery rate Quiet and powerful vacuum pump Specific protocol for fat removal Clinical Applications Despite being a widely used procedure, there are known risks associated with blood transfusion. Adverse events are still found in clinical practice related either directly or indirectly to homologous blood transfusion. Autotransfusion plays a key role as part of an effective blood management strategy. It can contribute to improved clinical outcomes in a cost-effective manner, either as stand-alone or as part of a Patient Blood Management program. In Cardiac Surgery Patients undergoing cardiac surgeries are commonly at an advanced stage and comorbidities such as myocardial infarction, making effective blood products management an essential component of their care. Autotransfusion lowers the transfusion rates during and after Cardiac Surgery. Outside of Cardiac Surgery The rate of allogeneic red blood cell transfusions in non-cardiac surgery settings has been found to be between 21% and 70%, with the majority of authors reporting figures in the middle of the range. Allogeneic blood transfusion raises multiple challenges: Risk of pathogen transmission Health/economic costs Scarcity of resources